Meininger, V., Genge, A., van den Berg, L. H., Robberecht, W., Ludolph, A., Chio, A., Kim, S. H., Leigh, P. N., Kiernan, M. C., Shefner, J. M., Desnuelle, C., Morrison, K. E., Petri, S., Boswell, D., Temple, J., Mohindra, R., Davies, M., Bullman, J., Rees, P., Lavrov, A., & , (n.d.). safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet neurology, 16(3), 208–216. http://access.bl.uk/ark:/81055/vdc_100041522467.0x00004e